Randomized controlled trial of Tesomet for weight loss in hypothalamic obesity.
Kim HuynhMarianne KloseKim KrogsgaardJørgen DrejerSarah BybergSten MadsbadFaidon MagkosAbdellatif AharazBerit EdsbergJacob Tfelt-HansenArne Vernon AstrupUlla Feldt-RasmussenPublished in: European journal of endocrinology (2022)
Tesomet was welltolerated, did not affect heart rate or blood pressure, and resulted in significant reductions in body weight compared to placebo in adults with hypothalamic obesity.
Keyphrases
- heart rate
- weight loss
- blood pressure
- body weight
- randomized controlled trial
- heart rate variability
- bariatric surgery
- insulin resistance
- roux en y gastric bypass
- metabolic syndrome
- weight gain
- high fat diet induced
- type diabetes
- study protocol
- hypertensive patients
- glycemic control
- skeletal muscle
- systematic review
- clinical trial
- phase iii
- obese patients